Sh Fosun Pharma reported CNY591.63M in EBIT for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Cspc Pharmaceutical 1093:HK CNY 1.99B 40.13M
Jiangsu Hengrui Me. 600276:CH CNY 1.07B 234.47M
Sh Pharmaceutical 601607:CH CNY 1.99B 469.7M
WuXi AppTec 603259:CH CNY 2.59B 54.01M